Inorganic materials can solve transportable and on-site hydrolytic hydrogen generation issues.CaH_(2)/(Al/Si)composites are preferable due to their notable chemical properties.However,these composites require pretreat...Inorganic materials can solve transportable and on-site hydrolytic hydrogen generation issues.CaH_(2)/(Al/Si)composites are preferable due to their notable chemical properties.However,these composites require pretreatments,an inert environment,and long hours of physical ball milling for high homogeneity and synergistic effects.CaH_(2)also inhibits the hydrolysis reaction by forming its products on the Al/Si surface,which hinders the direct utilization of composites.This work represents the first investigation of NaH-CaH_(2)(Al/Si)fuel composites,which greatly overcome these limitations and can be directly used for on-site hydrogen generation and proton exchange membrane(PEM)fuel cells.The NaH-CaH_(2)(Al/Si)fuel composites were prepared by using a straightforward mixing method with variable composition ratios,showing high H_(2)yield and fuel cell(FC)performance.NaH addition provides the bridge effect,which opens up a new way to enable efficient hydrolysis and greatly enhances the hydrolysis activity of CaH_(2)/(Al/Si)composites.The novel fuel composites(NaH-CaH_(2)/Al)have extraordinary FC performance and a 0.42 W/cm2 peak power density greater than commercial hydrogen generators.It provides high H_(2)yield 84.4%for NaH-CaH_(2)/Al and 82%for NaH-CaH_(2)/Si compared to NaOH-CaH_(2)(Al/Si),NaCl-CaH_(2)(Al/Si),and KCl-CaH_(2)(Al/Si)composites.The NaH bridge effect hinders the direct water contact and stops the formation of Ca(OH)2 around Al/Si,which provides adequate pathways for the CaH_(2)(Al/Si)hydrolysis.The impressive capabilities of novel fuel composites are anticipated to offer practical uses in fuel cells,automobile applications,and portable/on-board H_(2)generation.展开更多
Developing effective and long-term treatment strategies for rare and complex neurodegenerative diseases is challenging. One of the major roadblocks is the extensive heterogeneity among patients. This hinders understan...Developing effective and long-term treatment strategies for rare and complex neurodegenerative diseases is challenging. One of the major roadblocks is the extensive heterogeneity among patients. This hinders understanding the underlying disease-causing mechanisms and building solutions that have implications for a broad spectrum of patients. One potential solution is to develop personalized medicine approaches based on strategies that target the most prevalent cellular events that are perturbed in patients. Especially in patients with a known genetic mutation, it may be possible to understand how these mutations contribute to problems that lead to neurodegeneration. Protein–protein interaction analyses offer great advantages for revealing how proteins interact, which cellular events are primarily involved in these interactions, and how they become affected when key genes are mutated in patients. This line of investigation also suggests novel druggable targets for patients with different mutations. Here, we focus on alsin and spastin, two proteins that are identified as “causative” for amyotrophic lateral sclerosis and hereditary spastic paraplegia, respectively, when mutated. Our review analyzes the protein interactome for alsin and spastin, the canonical pathways that are primarily important for each protein domain, as well as compounds that are either Food and Drug Administration–approved or are in active clinical trials concerning the affected cellular pathways. This line of research begins to pave the way for personalized medicine approaches that are desperately needed for rare neurodegenerative diseases that are complex and heterogeneous.展开更多
基金financial support granted by the National Natural Science Foundation of China (No. 22402225)the Gusu Innovation and Entrepreneurship Leading Talent Plan(No. ZXL2023193)+2 种基金the Sinano Talents Plan (No. 2022000175)the Guangdong Basic and Applied Basic Research Foundation (No.2023A1515111133)the ANSO Scholarship for Young Talents
文摘Inorganic materials can solve transportable and on-site hydrolytic hydrogen generation issues.CaH_(2)/(Al/Si)composites are preferable due to their notable chemical properties.However,these composites require pretreatments,an inert environment,and long hours of physical ball milling for high homogeneity and synergistic effects.CaH_(2)also inhibits the hydrolysis reaction by forming its products on the Al/Si surface,which hinders the direct utilization of composites.This work represents the first investigation of NaH-CaH_(2)(Al/Si)fuel composites,which greatly overcome these limitations and can be directly used for on-site hydrogen generation and proton exchange membrane(PEM)fuel cells.The NaH-CaH_(2)(Al/Si)fuel composites were prepared by using a straightforward mixing method with variable composition ratios,showing high H_(2)yield and fuel cell(FC)performance.NaH addition provides the bridge effect,which opens up a new way to enable efficient hydrolysis and greatly enhances the hydrolysis activity of CaH_(2)/(Al/Si)composites.The novel fuel composites(NaH-CaH_(2)/Al)have extraordinary FC performance and a 0.42 W/cm2 peak power density greater than commercial hydrogen generators.It provides high H_(2)yield 84.4%for NaH-CaH_(2)/Al and 82%for NaH-CaH_(2)/Si compared to NaOH-CaH_(2)(Al/Si),NaCl-CaH_(2)(Al/Si),and KCl-CaH_(2)(Al/Si)composites.The NaH bridge effect hinders the direct water contact and stops the formation of Ca(OH)2 around Al/Si,which provides adequate pathways for the CaH_(2)(Al/Si)hydrolysis.The impressive capabilities of novel fuel composites are anticipated to offer practical uses in fuel cells,automobile applications,and portable/on-board H_(2)generation.
基金funded by NIH-NIA R01AG061708 (to PHO)Patrick Grange Memorial Foundation (to PHO)+1 种基金A Long Swim (to PHO)CureSPG4 Foundation (to PHO)。
文摘Developing effective and long-term treatment strategies for rare and complex neurodegenerative diseases is challenging. One of the major roadblocks is the extensive heterogeneity among patients. This hinders understanding the underlying disease-causing mechanisms and building solutions that have implications for a broad spectrum of patients. One potential solution is to develop personalized medicine approaches based on strategies that target the most prevalent cellular events that are perturbed in patients. Especially in patients with a known genetic mutation, it may be possible to understand how these mutations contribute to problems that lead to neurodegeneration. Protein–protein interaction analyses offer great advantages for revealing how proteins interact, which cellular events are primarily involved in these interactions, and how they become affected when key genes are mutated in patients. This line of investigation also suggests novel druggable targets for patients with different mutations. Here, we focus on alsin and spastin, two proteins that are identified as “causative” for amyotrophic lateral sclerosis and hereditary spastic paraplegia, respectively, when mutated. Our review analyzes the protein interactome for alsin and spastin, the canonical pathways that are primarily important for each protein domain, as well as compounds that are either Food and Drug Administration–approved or are in active clinical trials concerning the affected cellular pathways. This line of research begins to pave the way for personalized medicine approaches that are desperately needed for rare neurodegenerative diseases that are complex and heterogeneous.
